Camurus AB Owners | StatInvestor

Health Care & Life Sciences » Pharmaceuticals | Camurus AB

Camurus AB | Ownership

Companies that own Camurus AB

Name

Shares Held

% Shares Out

Change In Shares

% of Assets

As of Date

Max Mitteregger Kapitalförvaltning AB

1,812,500

4.72%

66,351

4.9%

12/31/2017

Swedbank Robur Fonder AB

1,277,962

3.33%

0.02%

07/31/2018

Catella Fondförvaltning AB

1,070,424

2.79%

-6,767

0.26%

08/31/2018

SEB Investment Management AB

951,269

2.48%

-888

0.03%

12/31/2017

Fjärde AP-fonden

797,731

2.08%

0.04%

12/31/2017

Norron AB

689,757

1.8%

-3,897

0.41%

08/31/2018

Enter Fonder AB

682,865

1.78%

59,500

1.14%

12/31/2017

Skandia Investment Management AB

13,929

0.04%

07/31/2018

Case Kapitalförvaltning AB

12,000

0.03%

12,000

0.2%

06/30/2017

Tredje AP-fonden

11,037

0.03%

06/30/2017

About Camurus AB

View Profile

Address	Ideon Science Park Lund SN 223 70 Sweden
Employees	-
Website	http://www.camurus.com
Updated	07/08/2019
Camurus AB engages in the research, development, and commercialization of specialty medicines. It provides its products for the treatment of severe and chronic conditions, which includes opioid dependence, pain, cancer, and endocrine disorders. The company was founded by Kare Larsson in 1991 and is headquartered in Lund, Sweden.